CERK and cancer: The observation that, in mice bearing the C26 or LLC tumor the down-regulation of CerK is associated with body weight loss, muscle mass depletion and atrogin-1/MAFbx overexpression, unravels a new potential pathogenetic mechanism accounting for the alterations of muscle homeostasis in cancer cachexia.